Non-pharmacological Treatment for Essential Isolated Systolic Hypertension in Elderly
NCT ID: NCT02200926
Last Updated: 2016-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-07-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We, therefore, aim to study the effect of slow loaded breathing training by using Breathmax on blood pressure at rest and exercise in elderly with essential isolated systolic hypertension and also investigate the autonomic function and others that may be involved with the changed blood pressure in elderly with essential isolated systolic hypertension. We hypothesized that slow loaded and unloaded breathing training could reduce resting and exercising blood pressure in elderly with essential isolated systolic hypertension.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Loaded Breathing Training in Essential Hypertension
NCT00791986
Treating Hypertension With Breath Control
NCT01285193
Effect of Pursed-Lip Breathing on Blood Pressure and Heart Rate
NCT04572672
Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure
NCT07018128
Breathe: Slow Paced Breathing to Lower Blood Pressure
NCT00328016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After 8 weeks of breathing training, the sustainability of breathing training effect will be assessed. Subjects in both breathing training groups (LB and ULB) will be stop breathing training with Breathmax and change to breathing normally. In contrast with the subjects in control group, they will be divided to 2 subgroups. The first subgroup performed loaded breathing training at the loaded of 18 cmH2O. The another subgroup performed unloaded breathing training at the loaded of 0 cmH2O. Breathing frequency will be control at 6 breaths/minute in both subgroups. The training program will be performed at home for 30 minutes/day, 7 days/week for 8 weeks.
Data collection will be carried out for 4 times: (1) before control, (2) before training, (3) after training and (4) after stop training. All measurement will be done in the cardiovascular laboratory room, department of physical therapy, faculty of associated medical sciences. In addition, self measurement of blood pressure and heart rate will be conducted at home every morning after getting up at the same time throughout the study (from week 0 to 18).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
The breathing was performed normally in this groups.
Placebo
7 days/week, for 8 weeks
Loaded breathing training
subjects will trained to inspire deeply against the resistance setting by using BreathMAX® at the loaded of 18 cmH2O with breathing frequency control at 6 breaths/minute. Breathing pattern will be controlled at duty cycle of 0.4 (inspiratory time = 4 sec and total respiratory time = 10 sec). The training program will be performed at home for 30 minutes/day, 7 days/week for 8 weeks.
Loaded breathing training
7 days/weeks, for 8 weeks
Unloaded breathing training
subjects will trained to inspire deeply (no resistance) with breathing frequency control at 6 breaths/minute. Breathing pattern will be controlled at duty cycle of 0.4 (inspiratory time = 4 sec and total respiratory time = 10 sec). The training program will be performed at home for 30 minutes/day, 7 days/week for 8 weeks.
Unloaded breathing training
7 days/week, for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Loaded breathing training
7 days/weeks, for 8 weeks
Unloaded breathing training
7 days/week, for 8 weeks
Placebo
7 days/week, for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good communication
Exclusion Criteria
* History of respiratory disease, heart disease, renal disease, blindness, deafness and cerebrovascular disease.
60 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khon Kaen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjarat Sangthong
Cardiopulmonay research, Faculty of associated medical science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjarat Sangthong, M.Sc.
Role: PRINCIPAL_INVESTIGATOR
Faculty of associated medical science, Khon Kaen University, thailand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of associated medical science, Khon Kaen University
Muang, Changwat Khon Kaen, Thailand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jones CU, Sangthong B, Pachirat O. An inspiratory load enhances the antihypertensive effects of home-based training with slow deep breathing: a randomised trial. J Physiother. 2010;56(3):179-86. doi: 10.1016/s1836-9553(10)70023-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
change1me
Identifier Type: REGISTRY
Identifier Source: secondary_id
BSangthong
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.